C22H23ClN4O7S
523 g/mol
APIDanger
LENVATINIB MESYLATE
CAS857890-39-2
Category
API
Compound Class
Other
Primary Use
Pharmaceutical Raw Material
Lenvatinib mesylate is a methanesulfonate salt of lenvatinib, a multi-kinase inhibitor. It is a pharmaceutical raw material used in the manufacturing of medications for cancer research and development.
Pharmaceutical raw material for multi-kinase inhibitor formulationsResearch compound for receptor protein-tyrosine kinase inhibition studies
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 857890-39-2
Related Compounds
ReferenceSame Category
Lincomycin hydrochloride
CAS859-18-7
pharmaceutical raw material
ReferenceSame Category
Amodiaquine
CAS86-42-0
pharmaceutical raw material
ReferenceSame Category
Dimethisoquin
CAS86-80-6
pharmaceutical raw material
ReferenceSame Category
Gadopentetate dimeglumine
CAS86050-77-3
pharmaceutical raw material
Safety Reference
Danger
H302Harmful if swallowed
H360May damage fertility or the unborn child
H361Suspected of damaging fertility or the unborn child
H362May cause harm to breast-fed children
H372Causes damage to organs through prolonged or repeated exposure
H373May cause damage to organs through prolonged or repeated exposure
Identifiers
IUPAC Name
4-[3-chloro-4-(cyclopropylcarbamoylamino)phenoxy]-7-methoxyquinoline-6-carboxamide;methanesulfonic acid
InChIKey
HWLFIUUAYLEFCT-UHFFFAOYSA-N
SMILES
COC1=CC2=NC=CC(=C2C=C1C(=O)N)OC3=CC(=C(C=C3)NC(=O)NC4CC4)Cl.CS(=O)(=O)O
Synonyms (22)
- Lenvatinib mesylate (USAN)
- 857890-39-2 (mesylate)
- E7080 MESYLATE
- LENVATINIB MESYLATE
- Lenvatinib mesilate
- Lenvatinib mesilate (JAN)
- Lenvatinib methanesulfonate
- Lenvima
- Lenvima (TN)